https://nj.mind-sys.net/users/login
MIND2: 不動産管理システム Users
users
https://pubmed.ncbi.nlm.nih.gov/37171597/
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab...
RE-MIND2 (NCT04697160) compared patient outcomes from the L-MIND (NCT02399085) trial of tafasitamab+lenalidomide with those of patients treated with other...
comparative effectivenesspluslenalidomideversus